Autres langues Metagenomi, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/06/2024			Varia. 5j.	Varia. 1 janv.
6,63 ^USD	+1,22%		+3,76%	0,00%

14/05	Metagenomi, Inc. annonce ses resultats pour le premier trimestre clos le 31 mars 2024	CI
07/05	METAGENOMI, INC. : HC Wainwright optimiste sur le dossier	ZM

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference	29/05
Metagenomi: Q1 Earnings Snapshot	14/05
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results	14/05
Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
North American Morning Briefing : Apple, Amgen -2-	03/05
Metagenomi, Inc. and Modernatx, Inc. Terminate the Strategic Collaboration and License Agreement	01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems	01/05
Metagenomi to Present at Upcoming Scientific Meetings	08/04
Metagenomi to Present at Upcoming Scientific Meetings	08/04
Metagenomi 2023 Loss Widens, Revenue Rises	27/03
Metagenomi Reports Business Updates and Full Year 2023 Financial Results	27/03
Metagenomi, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Metagenomi, Inc.(NasdaqGS:MGX) added to S&P TMI Index	18/03
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference	29/02
Metagenomi Closes $93.8 Million IPO	14/02
Metagenomi Announces Closing of Initial Public Offering	13/02
Metagenomi Announces Closing of Initial Public Offering	13/02
Metagenomi, Inc.(NasdaqGS:MGX) added to NASDAQ Composite Index	12/02
Metagenomi, Inc. has completed an IPO in the amount of $93.75 million.	08/02
Metagenomi, Inc. has filed an IPO in the amount of $100 million.	05/01

Aucun résultat pour cette recherche